Authors
Latest:
Specialty Pharmaceuticals and the Emergence of Sub-Specialty Pharmacy‘Ultra-orphan’ diseases will alter the specialty distribution process
Latest:
Drug shortages are opening the door to price gougingHospital pharmacies need to be vigilant in ensuring safe supplies of scarce drugs
Latest:
Is tech running you? Four ways to retake controlModern training technologies make the prospect of days-long training courses an obsolete practice
Latest:
The clear and present danger of counterfeit drugsProspects for international policing of counterfeit drugs is dim
Latest:
Industry should reinforce cargo security practices with TAPA participationUltimately, supply chain integrity should include both temperature control and security against theft or diversion
Latest:
The right supply chain prescriptionWhile pharma manufacturers may be concerned about the impact of item-level inventory tracking, it's an idea that actually makes great business sense
Latest:
The convergence of international and US pricing controlsNew approaches, and new skill sets are necessary for meeting the challenges of global drug reimbursement policies
Latest:
Common misconceptions about the orphan drug designationThings to know about the increasingly popular--and competitive--orphan drug space
Latest:
Building an Alternative Distribution Model for Ultra-Orphan DiseasesBiopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services
Latest:
Rare disease patient supportRare diseases are hard to treat; supporting the patient can be even more challenging
Latest:
Data as a strategic asset in the life sciencesBuilding in the right processes and support for data quality, standards, and governance
Latest:
A Roadmap to Optimizing Marketing OperationsUnifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings
Latest:
A New Business Model for Pharma InnovationThe studio model: how film industry practices can boost pharmaceutical creativity
Latest:
ACOs raise the stakes for evidence-based medicineManufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Latest:
Is your corporate board equipped to monitor incentive programs?Compliance officers at pharma companies need to ensure that the right mechanisms are in place for monitoring sales and business incentives
Latest:
A New Business Model for Pharma InnovationThe studio model: how film industry practices can boost pharmaceutical creativity
Latest:
The potential of translational research for new medicinesThe proposed federal National Center for Advancing Translational Sciences holds promise for drug development
Latest:
Legal uncertainties in the DSCSAThe Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification
Latest:
Accelerating the drive toward patient centricityGetting away from the traditional product-centric management structure is not easy; here’s how to do it
Latest:
Medical-Claims Database Analysis of Off-Label PrescribingExamining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage
Latest:
Organizing Your Commercial Compliance ProgramsRegulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels
Latest:
How to prepare a cold chain for looming COVID-19 demandsAgile approaches to averting vaccine wastage will be critical to global delivery ramp-up
Latest:
Include the sales force in incentive compensationBy working with the sales force, incentive plan design can boost a product launch
Latest:
Adopting the TAPA cargo security standards in the pharmaceutical industrySecuring your supply chain
Latest:
Supply chain issues for 2012Tompkins International's annual preview of key pharma supply chain issues
Latest:
Getting from multichannel marketing to customer-centric marketingToday's pharma marketers have the tools to refine their communication efforts to prescribers and patients
Latest:
Rethinking Sample DistributionAs the number of specific services associated with sample distribution has grown, so has the number of service providers a manufacturer might use. It’s time to think about consolidating these services
Latest:
When serializing packages for e-pedigree, go randomThe looming California e-pedigree standards do not specify how to generate product codes, but random codes are easy to produce and essential for supply chain security
